Nelipak Opens Asia-Pacific Technical Development Center In Singapore

At a time when pharmaceutical and medical device companies must shorten time to market without compromising safety, compliance, or performance, Nelipak’s integrated model for flexible and rigid sterile barrier packaging under one roof carries clear strategic significance.

Singapore as a new regional anchor for technical capability

Nelipak describes the new facility as a major milestone in its global growth strategy. More importantly, it establishes a long-term technical and innovation presence in one of the world’s fastest-growing centers for medical devices, biomedical technologies, and healthcare manufacturing. Singapore’s attractiveness is evident: strong global connectivity, expanding biomedical production capacity, and a strategic role as a regional gateway across Asia-Pacific.

From this location, Nelipak will support customers across Southeast Asia, China, Japan, Korea, India, Australia, and New Zealand. The center is designed to operate in real time with Nelipak’s global manufacturing and innovation network, ensuring that solutions developed in Asia-Pacific are not only tailored to regional needs but also globally scalable and ready for industrial production.

Nelipak positions the Singapore center as more than an additional technical site. It is intended as a platform for closer collaboration with pharmaceutical and medical device manufacturers across Asia. By locating design, prototyping, and validation support nearer to customers, the company can shorten iteration cycles, reduce technical fragmentation, and accelerate the path to market.

From device concept to validation-ready packaging design

The center’s most practical value lies in direct collaboration with customers from the earliest stages of product development. Under Nelipak’s model, customers can arrive with a medical device concept and leave with a validation-ready packaging design, supported by physical samples for further development. For companies under pressure to move faster without sacrificing safety or regulatory compliance, this is an immediate and measurable advantage.

The facility supports the development of custom sterile barrier packaging solutions that integrate both flexible and rigid formats. This is especially important for projects requiring ISO 11607-compliant development. Beyond initial design, the center is equipped to support line extensions, material transitions, risk mitigation efforts, and packaging changes driven by sterilization methods, regulatory requirements, or supply chain resilience priorities.

A new supply chain advantage in combining rigid and flexible packaging

In healthcare, sterile packaging is no longer just a protective layer. It is increasingly a strategic capability tied to risk management, regulatory compliance, logistics efficiency, and commercialization speed. By bringing rigid and flexible packaging development into one location, Nelipak can optimize the sterile barrier system as a whole instead of advancing isolated components separately. This reduces delays, improves validation consistency, and minimizes technical fragmentation throughout development.

CEO Pat Chambliss has emphasized that Asia-Pacific is an important and fast-growing region for medical device innovation, manufacturing, and consumption. Aldin Velic, Vice President and General Manager for Asia-Pacific, has likewise stressed the need to replace distance, delay, and fragmentation with expertise, speed, and collaboration. Their comments indicate that this investment is not simply about market presence; it is also about reshaping how technical support is delivered to the medtech sector in the region.

Singapore’s Economic Development Board noted that the new center will enable Nelipak to work more closely with pharmaceutical and medical device companies in the region, helping accelerate product development and launches. The investment also adds momentum to Singapore’s growing biomedical sciences ecosystem and reinforces its standing as a medtech innovation hub in Asia.

With more than 1,600 employees and 14 sites worldwide, Nelipak continues to strengthen its position as a global provider of healthcare packaging solutions spanning design, prototyping, simulation, validation, laboratory services, and cleanroom manufacturing. The new Singapore center therefore represents not just another technical facility, but a strong signal that sterile packaging is becoming a strategic pillar of modern healthcare supply chains, where speed, rigor, and real-time collaboration increasingly define competitiveness.

-----------

Source: Nelipak’s

By Trung Nguyen